reference/33734134

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33734134

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study
endingPage	3276
issn	1557-3265 1078-0432
issueIdentifier	13
pageRange	3269-3276
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	3269
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fb10b50fb8b379d63d0c54af69992c94
bibliographicCitation	Beatty GL, O'Dwyer PJ, Clark J, Shi JG, Bowman KJ, Scherle PA, Newton RC, Schaub R, Maleski J, Leopold L, Gajewski TF. First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. Clin Cancer Res. 2017 Jul 01;23(13):3269–76. PMID: 28053021; PMCID: PMC5496788.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5bd4252e27954adce355a0330180f82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_425dd6e62e6b33850936dc467daea642 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bb8e6e9bfb9bb27392113b826b36ea9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24576c08916e661d070935a8a4d51e4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca75e8c4354591a9900953bdc38d3795 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bf46ae2f667749b0a849d318a692dc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d385488543f34cbcb03937beec35fe5c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afdd7b0161dff53e71965a7ca5e05f2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_672548ecdee0b51e621485a831089f1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b217ef116cb4133d30e36466ca3276bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73b157a14561997850863f125cb6dbf1
date	2017-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5496788 https://pubmed.ncbi.nlm.nih.gov/28053021 https://doi.org/10.1158/1078-0432.ccr-16-2272
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies
discusses	http://id.nlm.nih.gov/mesh/M000626005 http://id.nlm.nih.gov/mesh/M0475654 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0015653
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D010091Q000008 http://id.nlm.nih.gov/mesh/D064420Q000473 http://id.nlm.nih.gov/mesh/D013449Q000008 http://id.nlm.nih.gov/mesh/D050503Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D064420Q000145 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009369Q000235 http://id.nlm.nih.gov/mesh/D009369Q000473 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D050503Q000037 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135424953 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1aa5b90ebc4a2c73e845fc0f1a4ccc3b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID846 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122074 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6910 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7008 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7353 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135564890 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10051 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9772 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3620

Total number of triples: 76.